NCTId,LeadSponsorName,CollaboratorName,DesignPrimaryPurpose,Phase,EnrollmentCount,CompletionDate,LocationCountry,LocationStatus
NCT04381962,University of Oxford,Pfizer,Treatment,Phase 3,800,2020-10-13,United Kingdom,Recruiting
NCT04412252,Pfizer,Not Applicable,Treatment,Phase 2,0,2020-10-18,United States,Unknown
NCT04469114,Hospital Israelita Albert Einstein,Pfizer,Treatment,Phase 2,260,2021-01-31,Brazil,Recruiting
NCT04535167,Pfizer,Not Applicable,Treatment,Phase 1,56,2021-03-21,United States,Recruiting
NCT04575610,Yale University,Pfizer,Treatment,Phase 2,68,2021-03-31,United States,Unknown
NCT04366050,"University of California, San Diego",Pfizer,Treatment,Phase 2,560,2021-05-01,United States,Unknown
NCT04588480,BioNTech SE,Pfizer,Prevention,Phase 1,160,2021-11-30,Japan,Unknown
NCT04368728,BioNTech SE,Pfizer,Prevention,Phase 2,43998,2022-12-11,United States,Recruiting
